Dr. Inderbir Singh Gill, MD

Dr. Gill practices at Urology - Nch Urology - HOPD in Los Angeles, California.

Dr. Gill's NPI, 1649234014, was assigned on April 13, 2006. Dr. Gill graduated from Government Medical College Patiala in 1979. Dr. Gill holds California license C53678.

Dr. Gill's primary practice is Urology - Nch Urology - HOPD, at 1516 San Pablo St, Los Angeles, CA 90033.

Dr. Gill's primary practice is Urology - Nch Urology - HOPD in Los Angeles, California. Dr. Gill is also affiliated with Keck Hospital of USC. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Gill to 2 more hospitals, 2 hospital outpatient departments and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gill practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Gill's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Gill is board certified in urology by the American Board of Urology. Dmand AI has Dr. Gill's licenses on file in 3 states: California, Ohio and Iowa.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, prostate cancer and prostate surgery among the conditions Dr. Gill treats.

CMS data shows 367 Medicare services from Dr. Gill across 9 procedure codes in 2024, for 237 Medicare patients. Medicare paid $93,389 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 237 Medicare patients who saw Dr. Gill in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gill's median patient age at 72, with 18% women.

In 2019, Dr. Gill wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $81 in total drug cost. In 2018, CMS named 40 claims across 2 drugs.

Dr. Gill accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gill as offering telehealth. CMS counts 22 procedures of prostate resection by Dr. Gill, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 75 papers to Dr. Gill, published from 2004 to 2025. 2018 was the busiest year, with 13. The most frequent topics are Prostatic Neoplasms, Artificial Intelligence and Prostatectomy. Dr. Gill has published most often in Eur Urol. Dr. Gill's most frequent co-authors are Mihir M. Desai, MD, Monish Aron, MD and Osamu Ukimura, MD, PhD.

Dmand AI links Dr. Gill to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Transitional Cell, Urinary Bladder, Neurogenic and Carcinoma. University of Southern California sponsors the most, 3.

CMS Open Payments shows 23 general payments to Dr. Gill from 6 drug and device companies from 2017 to 2025. Education make up the largest share, 74% of the total. Intuitive Surgical, Inc. paid the most, $4,880.

Dmand AI lists 34 awards for Dr. Gill, most recently Scientific innovations in robotic and laparoscopic oncologic surgery in 2022. Dr. Gill serves on The Journal of Urology.

Dr. Gill graduated from Government Medical College Patiala in 1979. Dr. Gill is a member of AUA.

Dr. Gill is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.